STEPHAN JACKMAN - CEO ALZAMEND NEURO : New Lithium-based Drug that Offers Alzheimer's Patients Hope.
In Episode 79 of Love Conquers Alz, host Susie speaks with Stephan Jackman, CEO of Alzamend Neuro. They discuss AL001, a new lithium-based drug, and AL002, a cell-based therapeutic vaccine, both aimed at treating Alzheimer's disease.